How to succeed as a DiGA: AMA with DiGA pioneers

When Germany launched DiGA in 2019, it was the envy of the healthtech world. The first dedicated pathway for digital therapeutics worldwide. Finally, a pathway not just to market, but to reimbursement, that made sense. With characteristic German efficiency, DiGA was rolled out and the tech companies rolled in. So impressive was DiGA that Emmanuel Macron himself made sure that France set up their own version, leading to the launch of PECAN. But was it lauded too much? What started in a blaze of expectations, hasn't disappointed exactly, but it hasn't been the trailblazing world-changing pathway many thought it could be. It remains an excellent pathway into the largest European healthcare market and there is a lot to be learnt from DiGA pioneers. With prices lower than expected and prescription numbers rising slowly, what will it take to get DiGA to fulfil its promise?